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Introduction
Metachromatic leukodystrophy (MLD) is one of the rarest lysosomal disorders, 
caused because of arylsulfatase A enzyme deficiency. MLD is classified to three 
types include late infantile, juvenile and adult form (1). MLD is one the diseases, 
which deteriorate rapidly and occur during the first years of age (2, 3). This disorder 
can cause the loss of function in cognitive and motor also lead to extensive damage 
in white matter (4). Signal hyperintensities can be found on brain MRI (5) with 
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Abstract
Objective
Metachromatic leukodystrophy disorder (MLD) is one of the rare neurometabolic 
diseases caused due to lack of saposin B and arylsulfatase A enzyme deficiency.
Materials & Methods
Eighteen patients diagnosed as metachromatic leukodystrophy in the Neurology 
Department of Mofid Children’s Hospital in Tehran, Iran between 2010 and 
2014 were included in our study. The disorder was confirmed by clinical, 
EMG-NCV, arylsulfatase A enzyme checking and neuroimaging findings along 
with neurometabolic and genetic assessment from reference laboratory in Iran. 
We assessed age, gender, past medical history, developmental status, clinical 
manifestations, and neuroimaging findings of 18 patients with metachromatic 
leukodystrophy. 
results
From 18 patients, 80% were offspring from consanguineous marriages. A family 
history of metachromatic leukodystrophy disease was positive for four patients. 
Twelve patients had late infantile form of this disorder and six patients had juvenile 
form. A history of tonic type seizure was positive in 20% of the patients and tonic 
spasm was confirmed with clinical information. Electromyographgraphy (EMG) 
in 96% of patients was abnormal with demyelinating sensorimotor neuropathy 
pattern. MRI in all patients showed the leukodystrophic pattern as arcuate fibers 
sparing and subcortical rim in white matter and periventricular involvement. Our 
diagnosis was confirmed by EMG-NCV findings with sensorimotor neuropathy 
pattern and the assessment of arylsulfatase A enzyme function.
Conclusion
MLD is an inheritance metabolic disorder, which was confirmed by the 
assessment of arylsulfatase A enzyme function, peripheral blood leukocyte that 
assessed in a referral laboratory in Iran.
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results 
Patient information
Metachromatic leukodystrophy disease was confirmed 
in 18 patients (10 males and 8 females). The youngest 
and oldest of all were 18-months and 8 years old, 
respectively. The median age of both presenting and 
assessing signs and symptoms (late infantile and 
juvenile forms) was 42 months. Eighty percent of 
patients were offspring of consanguineous parents. 
Forty five percent of them had parents who were first 
cousins. The resting‘s parents were second cousins. A 
family history of Metachromatic leukodystrophydisease 
was positive for four patients.
Clinical results 
A prenatal history of patients showed a history of 
preeclampsia in one patient, which leaded to the 
cesarean section and neonate hospitalized for one day. 
Prenatal history revealed that two patients had a history 
of prematurity with gestational ages of 34 and 35 weeks 
(with normal weight and compatible with gestational age 
and no history of IUGR); one of them at neonatal period 
was admitted Neonatal Intensive care Unit because of 
mild respiratory distress and was discharged without 
any complication after 3 days. Of 18 patients with 
metachromatic leukodystrophy, 12 had late infantile 
form of this disorder, which was begun in 1.5-3 years of 
age, and they were normal before the diagnosis. 
The first and the most common complaint among 
the patients in neurological examination was ataxia, 
gait disorders and dysarthria. Seven patients with late 
infantile form of MLD showed cranial nerve impairment 
such as esotropia and strabismus. The mental and motor 
regressions process lasted about 10.5 months. A history of 
tonic type seizure was positive in 20% patients and tonic 
spasm was seen in 35% patients. Pyramidal involvement 
included spasticity and increased deep tendon reflex 
(DTR) seen in 45% of patients, decrease DTR in 35% 
and dystonia and extarpyramidal involvement in 34% of 
patients at admission time. All of tonicity was spastic. 
Ophthalmic and ear examinations showed visual 
impairment and ear involvement in four patients. After 
2 years of having this disorder, swallowing and feeding 
disorders (Dysphagia) were seen. 
Among patients with metachromatic leukodystrophy, six 
white and gray matter involvement. The accumulation 
of sulfatide in the kidneys, gallbladder and central 
and peripheral nervous system can cause many organ 
dysfunctions (6). As a natural course of MLD, the 
motor deterioration is a key feature (2). 
In this study, we present 4 years of experience on 
metachromatic leukodystrophy from the Pediatric 
Neurology Research Center of Mofid Children’s 
Hospital, Tehran, Iran. We describe clinical symptoms 
and neuroimaging findings of 18 cases with this 
disorder. 
Materials & Methods 
Subjects
This observational study was conducted in patients 
diagnosed as metachromatic leukodystrophy at the 
Neurology Department of Mofid Children’s Hospital in 
Tehran, Iran (2010–2014). Forty-seven patients (aged 
from 5 to 96 months) were enrolled in our study with 
features of neuro-developmental regression and white 
matter involvement with leukodystrophic pattern in 
brain MRI. The patients, who in spite of leukodystrophy 
in their brain MRI had other metabolites increased in 
their serum tandem mass spectrometry and the ones 
with high N-acetylaspartate (NAA) acid in their MRS 
(magnetic resonance spectroscopy) were excluded.
Patient information
Eighteen of patients were diagnosed as metachromatic 
leukodystrophy based on neuroimaging findings and 
decreased function of arylsulfatase A enzyme, assessed 
in the patients’ peripheral blood leukocytes in a referral 
laboratory in Tehran, Iran.
Data analysis
The data were analyzed in this observational study 
by descriptive methods and no statistical testing was 
applied. 
ethical approval
Institutional ethical approval for the conduct of this 
study was obtained from the Ethics Committee of 
Pediatric Neurology Research Center of Shahid 
Beheshti University of Medical Sciences, Tehran, Iran. 
All parents signed an informed consent for participation 
in the study. 
neuroradiological Findings of neurometabolic Disorders: an Iranian Pediatric Case Series
59Iran J Child Neurol. 2015 SUMMER  Vol 9 No 3
neuroradiological Findings of neurometabolic Disorders: an Iranian Pediatric Case Series
had juvenile form of this disorder, which was begun in 
3-6.5 years of age; 15% of them had mild speech delay 
and 12%  had motor delay, which had been compensated 
after 3 years. The patients with juvenile form of MLD 
showed findings as follows: the onset of symptoms 
in this group was started with ADHD and irritability; 
continued with gait impairment and drowsiness as 
well as gradually dysarthria. Seizure was seen in 25% 
of patients with dominancy of partial seizure. The 
progression of juvenile form was slower than late infantile 
form. Patients with juvenile form of metachromatic 
leukodystrophy had less cranial involvement and more 
ataxia than late infantile form. All of the patients had 
motor involvement and preneural neuropathy, which 
was one of the best points to be considered as the sign 
of metachromatic leukodystrophy. The other findings in 
physical examination were not remarkable.
Para clinical results
EMG-NCV in 96% of patients (both juvenile and late 
infantile form of metachromatic leukodystrophy) was 
abnormal with demyelinating sensorimotor neuropathy 
pattern. Visual and auditory involvement in patients 
with juvenile form of metachromatic leukodystrophy, 
assessed by physical examination, VEP and ABR were 
more than late infantile form (70% versus 45%).
neuroimaging results
MRI in all patients showed the leukodystrophic pattern 
as periventricular white matter involvement with U 
fiber and subcortical rim sparing (Figure 1). The first 
and best paraclinical choice for early detection after 
clinical findings was brain MRI, which showed the 
leukodystrophic pattern in all of the patients. 
Discussion 
Metachromatic leukodystrophy is one of the rare 
lysosomal diseases. In the late infantile form and 
juvenile form of this disorder, the motor deterioration is 
a key feature (7). 
Lugowska et al. showed that in patients with 
neuro imaging findings and ataxia, metachromatic 
leukodystrophy should be considered as diagnosis. Their 
diagnosis was based on demyelination in brain MRI and 
detection of low activity of arylsulfatase A (1). Our study 
showed the prevalence of gait impairment and ataxia in 
patients with metachromatic leukodystrophy. Wittig et 
al. reported two cases of infantile MLD in monozygotic 
twins. They were born from a second cousin marriage 
(8).
In our study, we showed 80% of patients were offspring 
of consanguineous marriages. Forty five percent of 
patients had parents who were first cousins and in 
other patients, their parents were second cousins. It 
means that in cases with developmental regression 
and consanguineous marriages the metachromatic 
leukodystrophy diagnosis should be considered. 
Prenatal history revealed that two patients had a 
history of prematurity with gestational ages of 34 and 
35 weeks. Congenital anomalies were not detected in 
any newborn babies at birth.  In a study, conducted on 
brain N-acetylaspartate level in 13 patients with late 
infantile metachromatic leukodystrophy, the positive 
association between NAA level, cognitive, and motor 
function was reported (3). Groeschel et al.  showed the 
decreased amount of gray matter in 18 patients with 
late infantile MLD (9). In our patients, MRI showed the 
leukodystrophic pattern as periventricular white matter 
involvement with U fiber and subcortical rim sparing in 
all of the patients.
Yang et al. showed the rapid and progressive 
regression of motor development in patients with late 
infantile MLD (10). Sevin et al. in their review article 
demonstrated the demyelination as a pathological 
hallmark in patients with MLD (11). Kehrer et al. in 
their study done on 59 patients including 27 males and 
32 females with MLD (21 late infantile MLD and 38 
patients with juvenile MLD) showed all the patients 
with late infantile MLD had loss of the all gross motor 
function and patients with juvenile MLD had a more 
variable motor decline (2). Twelve of 18 patients with 
metachromatic leukodystrophy in our study had late 
infantile form of this disorder, which was begun in 1.5-3 
years of age, and they were normal before the diagnosis. 
The progression of juvenile form was slower than late 
infantile form. Patients with juvenile form of MLD 
had less cranial involvement and more ataxia than late 
infantile form. 
Deconinck et al. presented a case of late infantile 
MLD disease with normal arylsulfatase A activity (4). 
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white matter involvement (13). 
Both the lower and upper motor neuron involvement are 
seen in patients with metachromatic leukodystrophy; 
therefore either absence or exaggeration of DTR should 
not sinister the diagnosis.
In conclusion, in patients with developmental regression, 
ataxia and gait disorder, peripheral neuropathy in NCV, 
leukodystrophy with specific pattern, positive familial 
history of MLD and consanguinity marriage of parent, 
Sensorimotor neuropathy pattern and brain imaging 
findings in our patients lead us to check the arylsulfatase 
A enzyme function. Eichler et al. reported the confluent 
T2 hyperintensities of white matter in 33 patients with 
MLD (10 patients with late infantile, 16 patients with 
juvenile and 2 patients with adult MLD) (12). Singh et 
al. showed the isolated cranial neuropathy, spastic gait 
and decreased level of leukocyte arylsulfatase A activity 
in a 25-month-old female without intraparenchymal 
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Fig 1.  A) axial T2WI MR shows the typical butterfly-shaped pattern of white matter involve ent in MLD. Note the 
sparing of internal/external capsules and subcortical U-fibers
b, C) Axial and Sag T2WI MR shows confluent, symmetric, hyperintense signal in the white matter.Multiple 
hypointense lines and dots within the white matter ~ create the characteristic “tigroid” or “leopard” pattern of MLD. 
The sparing of perivenular myelin is thought to account for this appearance 
D) Axial FLAIR MR demonstrates the characteristic confluent, symmetric, central white matter involvement of MLD. 
The “tigroid” or “leopard” pattern of lines and dots within the cerebral hemispheric white matter is evident.
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the diagnosis of MLD should be considered. 
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